Analyst Ratings for Myriad Genetics (MYGN)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/2/2011 | Ticonderoga | N/A | Upgrade | Buy (N/A) |
25.00 (N/A) |
20.33 (20.28) |
-0.25% | Details |
| 9/23/2011 | Goldman Sachs » Updated 11/2/2011 |
N/A | Upgrade | Neutral (N/A) |
22.00 (N/A) |
18.43 (20.28) |
10.04% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
